M. Funk

发表

Incidence of development of factor VIII and factor IX inhibitors in haemophiliacs

W. Kreuz, S. Ehrenforth, I. Scharrer, 1992, The Lancet.

Immune status of HIV and HCV negative haemophiliacs treated with Intermediate- purity factor VIII concentrates

W. Kreuz, S. Ehrenforth, M. Funk, 1993, The Lancet.

Epidemiology of inhibitors and current treatment strategies.

G. Auerswald, T. Klingebiel, C. E. Ettingshausen, 2003, Haematologica.

Factor VIII Inhibitors in Patients with Hemophilia A: Epidemiology of Inhibitor Development and Induction of Immune Tolerance for Factor VIII

G. Auerswald, C. Escuriola-Ettingshausen, G. Auerswald, 1995, Seminars in thrombosis and hemostasis.

Immune tolerance therapy in paediatric haemophiliacs with factor VIII inhibitors: 14 years follow‐up

G. Auerswald, W. Kreuz, S. Ehrenforth, 1995, Haemophilia : the official journal of the World Federation of Hemophilia.

Immune tolerance induction with mycophenolate‐mofetil in two children with haemophilia B and inhibitor

W. Kreuz, M. Funk, C. Heller, 2007, Haemophilia : the official journal of the World Federation of Hemophilia.

Combined therapy in human immunodeficiency virus-infected children —a 4-year experience

W. Kreuz, S. Ehrenforth, R. Linde, 1993, European Journal of Pediatrics.

Need for therapeutic drug monitoring in HIV-1 infected children receiving efavirenz doses according to international guidelines.

W. Kreuz, R. Linde, M. Funk, 2006, European journal of medical research.

Preliminary experiences with triple therapy including nelfinavir and two reverse transcriptase inhibitors in previously untreated HIV-infected children.

W. Kreuz, R. Linde, M. Funk, 1999, AIDS.

Modified magnetic resonance imaging score compared with orthopaedic and radiological scores for the evaluation of haemophilic arthropathy

T. Klingebiel, W. Kreuz, C. Escuriola, 2002, Haemophilia : the official journal of the World Federation of Hemophilia.

When should prophylactic treatment in patients with haemophilia A and B start?— The German experience

C. Kessler, C. Escuriola-Ettingshausen, W. Kreuz, 1998, Haemophilia : the official journal of the World Federation of Hemophilia.

Prevention of joint damage in hemophilic children with early prophylaxis

W. Kreuz, C. Escuriola Ettingshausen, M. Funk, 1999, Der Orthopäde.

Radiological and orthopedic score in pediatric hemophilic patients with early and late prophylaxis

C. Escuriola-Ettingshausen, W. Kreuz, M. Funk, 1998, Annals of Hematology.

Radiological score in paediatric haemophilic patients with early and late onset of factor VIII-prophylaxis.

S. Böttger, W. Kreuz, M. Funk, 1996, Thrombosis and haemostasis.

[Evaluation of haemophilic arthropathy--a comparison of MRI and Pettersson score].

W. Kreuz, M. Funk, H. Schmidt, 2002, RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin.

Valproate Therapy Induces von Willebrand Disease Type I

W. Kreuz, U. Nowak‐Göttl, I. Scharrer, 1992, Epilepsia.

[Prevention of joint damage in hemophilic children with early prophylaxis].

W. Kreuz, C. Escuriola Ettingshausen, M. Funk, 1999, Der Orthopade.

Variables that might affect the outcome of immune tolerance therapy in haemophiliacs with factor VIII inhibitors.

G. Auerswald, W. Kreuz, S. Ehrenforth, 1994, Thrombosis and haemostasis.

Prevention of Hepatitis C Virus Infestion in Children with Haemophilia A and B and von Willebrand’s Disease

G. Auerswald, W. Kreuz, R. Linde, 1992, Thrombosis and Haemostasis.

Nelfinavir pharmacokinetics in HIV-infected children: a comparison of twice daily and three times daily dosing.

M. Kurowski, W. Kreuz, R. Linde, 2000, AIDS.

Effect of first line therapy including efavirenz and two nucleoside reverse transcriptase inhibitors in HIV-infected children.

C. Königs, M. Stürmer, W. Kreuz, 2005, European journal of medical research.

Effect of antiretroviral combination therapies including efavirenz in heavily pretreated HIV-infected children.

J. Eberle, M. Funk, B. Belohradsky, 2002, European journal of medical research.

Elevated Plasma Levels of 90K (Mac-2 BP) Immunostimulatory Glycoprotein in HIV-1-Infected Children

S. Iacobelli, H. Doerr, J. Cinatl, 2000, Journal of Clinical Immunology.

Induction of von Willebrand disease type I by valproic acid

W. Kreuz, U. Nowak‐Göttl, I. Scharrer, 1990, The Lancet.

"Treating through" hypersensitivity to cotrimoxazole in children with HIV infection

W. Kreuz, M. Funk, B. Kornhuber, 1990, The Lancet.

Cytomegalovirus myelitis in perinatally acquired HIV.

W. Kreuz, R. Linde, M. Funk, 1993, Archives of disease in childhood.

Thrombophilia in a Child with CDG-Syndrome Type I

W. Kreuz, M. Funk, B. Pötzsch, 1995, Thrombosis and Haemostasis.

First experience with pentamidine inhalation in human immunodeficiency virus-infected children

W. Kreuz, S. Ehrenforth, R. Linde, 1991, European Journal of Pediatrics.

Low incidence of genotypic and phenotypic resistance in paediatric HIV-infected patients on long-term first-line antiretroviral triple therapy.

T. Klingebiel, W. Kreuz, R. Linde, 2001, AIDS.